Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GenturaDx Awarded Fifth Patent on Innovative Sample Prep Design

Published: Monday, March 26, 2012
Last Updated: Monday, March 26, 2012
Bookmark and Share
GenturaDx has been awarded its fifth patent from the U.S. patent office, which covers aspects of the sample cassette utilized by the IDbox™.

GenturaDx, has announced that is has been awarded its fifth patent from the U.S. patent office (U.S. Patent No. 8,124,024), which covers aspects of the sample cassette utilized by the IDbox™. The GenturaDx cassette design is part of the company's proprietary fully automated method of integrating extraction and purification of nucleic acids along with amplification and detection capabilities within the IDbox. This patent is specifically related to innovations within the integrated cassette that reduce the risk of Polymerase Chain Reaction (PCR) contamination that can cause false positive or erroneous results. By automating this important process, human error is minimized.

"The award of this patent supports our continued vision of bringing the highest quality of molecular diagnostic products to clinicians and patients. By simplifying these complex processes, we enable more health care providers with the most sensitive and accurate molecular tests," said GenturaDx Chief Scientific Officer Jesus Ching, Ph.D.

The fully integrated and automated design of the IDbox system will bring an easy-to-use, cost-effective and highly sensitive molecular testing capability to hospital laboratories. These laboratories will benefit from the decreased labor and enhanced workflow, while clinicians will benefit from receiving the most accurate result with rapid turnaround that ultimately allows for faster treatment and management of the patient. The company is currently performing clinical beta studies and heading towards clinical trials in third quarter 2012.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GenturaDx Announces Addition to Board of Directors
The newly appointed member, Michael Treble, is currently chairman and CEO of Axela, Inc. The five current directors will remain on the board.
Thursday, January 12, 2012
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Faecal Bacteria Linked to Body Fat
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!